SHF Holdings, Inc. (SHFS) Q3 2024 Earnings Call Transcript Summary
SHF Holdings, Inc. (SHFS) Q3 2024 Earnings Call Transcript Summary
The following is a summary of the SHF Holdings, Inc. (SHFS) Q3 2024 Earnings Call Transcript:
以下是SHF控股有限公司(SHFS)2024年第三季度業績會議呼叫交易摘要:
Financial Performance:
財務表現:
Q3 net income increased to $354,000 from a net loss of $748,000 year-over-year.
Loan interest income for Q3 grew by 48%, and for the first nine months of the year, it increased by 143.5%.
Q3 and 9-month operating expenses decreased by 13% and 66% year-over-year, respectively.
Total Q3 revenue was $3.5 million, a 19.6% decrease from the previous year.
Net income for the first nine months was $3.3 million, up from a net loss of $19.8 million year-over-year.
第三季度淨利潤從去年同期的748,000美元淨虧損增加至354,000美元。
第三季度貸款利息收入增長了48%,而今年前九個月增長了143.5%。
第三季度和前九個月的營業費用分別同比減少了13%和66%。
第三季度總收入爲$350萬,比上一年減少了19.6%。
前九個月的淨利潤爲330萬,較去年同期的1980萬淨虧損有所增加。
Business Progress:
業務進展:
Safe Harbor has continued to enhance its position as a leading financial services provider in the cannabis industry.
They have inaugurated a $1.07 million secured credit facility as part of a $5 million commitment to a Missouri-based cannabis operator.
Announced a partnership with BIPOCann to support minority-owned cannabis businesses.
Plans to concentrate on acquiring account portfolios and expanding its deposit base.
Safe Harbor不斷增強其作爲大麻股行業領先金融服務提供商的地位。
他們已爲一家總部位於密蘇里州的大麻運營商啓動了一項107萬美元的擔保信貸設施,作爲500萬美元承諾的一部分。
宣佈與BIPOCann合作,支持少數族裔擁有的大麻業務。
計劃專注於收購帳戶組合並擴大其存入資金基礎。
Opportunities:
機會:
The continued legalization of cannabis across additional states presents growth opportunities.
The potential reclassification of cannabis from Schedule I to Schedule III could significantly reduce tax burdens and level the playing field for cannabis businesses.
大麻在更多州的持續合法化提供了增長機會。
將大麻從第一類藥物重新分類爲第三類藥物的潛在可能性,可能會顯著減少稅負,併爲大麻業務創造更公平的競爭環境。
Risks:
風險:
Challenging market conditions including pricing pressures, excess supply, and increased competition have negatively impacted revenue.
Regulatory risks associated with the lack of consistent state-level regulation for CBD and THC derivatives under the 2018 Farm Bill.
具有挑戰性的市場條件,包括價格壓力、供應過剩和競爭加劇,已經對營業收入產生了負面影響。
根據2018年農業法案,缺乏一致的州級法規所帶來的與CBD和THC衍生物相關的監管風險。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由人工智能生成。內容的準確性無法得到完全保證。有關更全面的細節,請參考投資者關係網站。本文僅供投資者參考,不構成任何指導或建議。